Stock EVAX EVAXION BIOTECH A/S
Add to a list
To use this feature you must be a member
Log inSign up

Financials Evaxion Biotech A/S

Equities

EVAX

US29970R2040

Biotechnology & Medical Research

Market Closed - Nasdaq
Other stock markets
 04:00:00 2024-04-26 pm EDT 		5-day change 1st Jan Change
4.18 USD +1.46% Intraday chart for Evaxion Biotech A/S -3.02% -39.04%
Apr. 26 European Equities Traded in the US as American Depositary Receipts Trend Higher in Friday Trading, End Week Up 3.4% MT
Apr. 17 Evaxion Announces Phase 2 Clinical Trial Update CI

Valuation

Fiscal Period: December 2021 2022 2023 2024 2025 2026
Capitalization 1 102.3 42.84 25.99 21.8 - -
Enterprise Value (EV) 1 73.81 42.84 25.99 21.8 21.8 21.8
P/E ratio -3.51 x -1.81 x -8.47 x -3.01 x -2.12 x 6.74 x
Yield - - - - - -
Capitalization / Revenue - - - 3.48 x 1.19 x 0.34 x
EV / Revenue - - - 3.48 x 1.19 x 0.34 x
EV / EBITDA -4.01 x -1.74 x -1.2 x -2.06 x -4.11 x -1.45 x
EV / FCF -4,402,595 x -1,643,503 x - - - -
FCF Yield -0% -0% - - - -
Price to Book - - - - - -
Nbr of stocks (in thousands) 2,314 2,413 3,790 5,215 - -
Reference price 2 44.20 17.75 6.857 4.180 4.180 4.180
Announcement Date 3/22/22 4/27/23 3/26/24 - - -
1USD in Million2USD
Estimates

Income Statement Evolution (Annual data)

Fiscal Period: December 2019 2020 2021 2022 2023 2024 2025 2026
Net sales 1 - - - - - 6.267 18.26 63.59
EBITDA 1 - - -25.49 -24.61 -21.58 -10.6 -5.3 -15
EBIT 1 -10.86 -16.57 -25.83 -25.26 -22.2 -10.81 -3.152 42.17
Operating Margin - - - - - -172.51% -17.26% 66.33%
Earnings before Tax (EBT) 1 - -16.58 -24.71 -23.94 -22.92 -11.38 -3.811 41.97
Net income 1 -11.2 -15.02 -24.53 -23.17 -22.12 -11.18 -3.544 30.9
Net margin - - - - - -178.48% -19.41% 48.6%
EPS 2 - -9.700 -12.60 -9.800 -0.8100 -1.390 -1.970 0.6200
Free Cash Flow - - -23.23 -26.07 - - - -
FCF margin - - - - - - - -
FCF Conversion (EBITDA) - - - - - - - -
FCF Conversion (Net income) - - - - - - - -
Dividend per Share - - - - - - - -
Announcement Date 10/22/20 4/6/21 3/22/22 4/27/23 3/26/24 - - -
1USD in Million2USD
Estimates

Income Statement Evolution (Quarterly data)

Fiscal Period: December 2021 Q3 2021 Q4 2022 Q1 2022 Q2 2022 Q3 2022 Q4 2023 Q1 2023 Q2 2023 Q3 2023 Q4 2024 Q1 2024 Q2 2024 Q3 2024 Q4
Net sales 1 - - - - - - - - - - - - - -
EBITDA - - - - - - - - - - - - - -
EBIT 1 -5.912 -7.721 -6.399 -6.259 -6.083 -6.525 -6.394 -5.677 -5.762 -4.364 -4.156 -3.969 -3.926 -4.015
Operating Margin - - - - - - - - - - - - - -
Earnings before Tax (EBT) 1 -5.675 -7.047 -6.038 -4.945 -5.915 -7.045 -6.435 -5.908 -5.872 -4.7 -4.306 -4.119 -4.076 -4.165
Net income 1 -5.25 -8.37 -5.791 -4.768 -5.74 -6.872 -6.241 -5.683 -5.678 -4.523 -4.14 -3.96 -3.922 -4.012
Net margin - - - - - - - - - - - - - -
EPS 2 -2.700 -3.900 -2.500 -2.000 -2.400 -2.900 -2.400 -2.100 -2.100 -0.1500 -0.5550 -0.5000 -0.5100 -0.5200
Dividend per Share - - - - - - - - - - - - - -
Announcement Date 11/9/21 3/22/22 5/11/22 8/10/22 11/14/22 4/27/23 5/31/23 8/17/23 12/19/23 3/26/24 - - - -
1USD in Million2USD
Estimates

Balance Sheet Analysis

Fiscal Period: December 2019 2020 2021 2022 2023 2024 2025 2026
Net Debt - - - - - - - -
Net Cash position - - 28.5 - - - - -
Leverage (Debt/EBITDA) - - - - - - - -
Free Cash Flow - - -23.2 -26.1 - - - -
ROE (net income / shareholders' equity) - - - - - - - -
ROA (Net income/ Total Assets) - - - - - - - -
Assets 1 - - - - - - - -
Book Value Per Share - - - - - - - -
Cash Flow per Share - - - - - - - -
Capex - - 1.3 0.29 - - - -
Capex / Sales - - - - - - - -
Announcement Date 10/22/20 4/6/21 3/22/22 4/27/23 3/26/24 - - -
1USD in Million
Estimates

EPS & Dividend

Year-on-year evolution of the PER

Change in Enterprise Value/EBITDA

Analysts' Consensus

Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
3
Last Close Price
4.18 USD
Average target price
11.75 USD
Spread / Average Target
+181.10%
Consensus

EPS Revisions

Estimates Revisions

Quarterly earnings - Rate of surprise

Company calendar

Sector Other Biotechnology & Medical Research

1st Jan change Capi.
EVAXION BIOTECH A/S Stock Evaxion Biotech A/S
-39.04% 21.8M
IQVIA HOLDINGS INC. Stock Iqvia Holdings Inc.
+1.51% 42.75B
LONZA GROUP AG Stock Lonza Group AG
+49.22% 41.61B
MODERNA, INC. Stock Moderna, Inc.
+8.57% 41.34B
CELLTRION, INC. Stock Celltrion, Inc.
-12.36% 26.59B
ICON PUBLIC LIMITED COMPANY Stock ICON Public Limited Company
+8.92% 25.49B
ALNYLAM PHARMACEUTICALS, INC. Stock Alnylam Pharmaceuticals, Inc.
-25.13% 18.12B
MEDPACE HOLDINGS, INC. Stock Medpace Holdings, Inc.
+29.17% 12.24B
CHARLES RIVER LABORATORIES INTERNATIONAL, INC. Stock Charles River Laboratories International, Inc.
-3.12% 11.76B
UNITED THERAPEUTICS CORPORATION Stock United Therapeutics Corporation
+6.35% 11B
Other Biotechnology & Medical Research
  1. Stock Market
  2. Equities
  3. EVAX Stock
  4. Financials Evaxion Biotech A/S